Investigations of Tritiated Menadiol Sodium Diphosphate (T-MNDP) as a Radioactive Drug
Open Access
- 1 May 1974
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 29 (5) , 373-388
- https://doi.org/10.1038/bjc.1974.85
Abstract
An attempt has been made to develop tritiated derivatives of Synkavit (menadiol sodium diphosphate, MNDP) of high specific activity as a radioactive drug.Keywords
This publication has 23 references indexed in Scilit:
- Mechanisms of Selective Uptake of 2-Methyl-1, 4-Naphthoquinol Bis Disodium Phosphate, into some Mammalian Cells in Tissue CultureBritish Journal of Cancer, 1973
- Multiple-drug therapy for malignant solid tumors in adults.1973
- Labelled Compound Related to Synkavit and its Uptake in Certain Human Tumours Studied by Radio-Isotope ScanningActa Radiologica: Therapy, Physics, Biology, 1969
- Excretion of tritium after therapeutic injections of tritiated 2-methyl-1: 4-naphthaquinol diphosphate in cancer patientsInternational Journal of Cancer, 1967
- Investigation of a Radioactive Drug (TRA 119) With Special Reference to Autoradiographic and Related StudiesActa Radiologica: Therapy, Physics, Biology, 1963
- Laboratory and Clinical Studies of Some Quinol Diphosphates and Related Compounds as Chemical Radiosensitizers and the Development of a Radioactive Drug (Part 1 of 4)Chemotherapy, 1961
- Renal Aortography and Selective Renal ArteriographyPublished by Oxford University Press (OUP) ,1958
- The gamma-ray dose in carcinoma of the thyroid treated by radio-iodineActa Radiologica, 1954
- Toxicity of Tritium Oxide to MiceExperimental Biology and Medicine, 1952
- TRIETHYLENE MELAMINE IN THE TREATMENT OF NEOPLASTIC DISEASEA.M.A. Archives of Internal Medicine, 1951